Trends in decline of antiretroviral resistance among ARV-experienced patients in the HIV outpatient study: 1999-2008

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Buchacz, Kate ^a   Baker, Rose ^b   Ward, Douglas J ^c   Palella, Frank J ^d   Chmiel, Joan S ^d   Young, Benjamin ^e,f   Yangco, Bienvenido G ^g   Novak, Richard M ^h   Brooks, John T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CERNER CORPORATION   (United States)

^c Dupont Circle Physicians Group   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e DIDC Rocky Mountain CARES   (United States)

^f Health Connections International   (Netherlands)

^g Infectious Disease Research Institute   (United States)

^h UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873845936     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/230290     Document Type: Article

References (29)

1. Palella F. J. Jr., Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 1998 338 13 853 860 10.1056/NEJM199803263381301 (Pubitemid 28135961)
2. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., D'Arminio Monforte A., Knysz B., Dietrich M., Phillips A. N., Lundgren J. D., Decline in the AIDS and death rates in the EuroSIDA study: an observational study. The Lancet 2003 362 9377 22 29 2-s2.0-0038162585 10.1016/S0140-6736(03)13802-0 (Pubitemid 36835816)
3. Cozzi-Lepri A., Phillips A. N., Clotet B., Mocroft A., Ruiz L., Kirk O., Lazzarin A., Wiercinska-Drapalo A., Karlsson A., Lundgren J. D., Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study. AIDS 2008 22 16 2187 2198 2-s2.0-55249094827 10.1097/QAD.0b013e328310e04f
4. Phillips A. N., Leen C., Wilson A., Anderson J., Dunn D., Schwenk A., Orkin C., Hill T., Fisher M., Walsh J., Pillay D., Bansi L., Gazzard B., Easterbrook P., Gilson R., Johnson M., Sabin C. A., Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study. The Lancet 2007 370 9603 1923 1928 2-s2.0-36549034745 10.1016/S0140-6736(07)61815-7 (Pubitemid 350193334)
5. Hogg R. S., Bangsberg D. R., Lima V. D., Alexander C., Bonner S., Yip B., Wood E., Dong W. W. Y., Montaner J. S. G., Harrigan P. R., Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Medicine 2006 3 9 2-s2.0-33749021387 10.1371/journal.pmed. 0030356 e356 (Pubitemid 44455267)
6. Lucas G. M., Gallant J. E., Moore R. D., Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing. AIDS 2004 18 11 1539 1548 2-s2.0-3843122021 10.1097/01.aids.0000131339.68666.1a (Pubitemid 39037478)
7. Deeks S. G., Gange S. J., Kitahata M. M., Saag M. S., Justice A. C., Hogg R. S., Eron J. J., Brooks J. T., Rourke S. B., Gill M. J., Bosch R. J., Benson C. A., Collier A. C., Martin J. N., Klein M. B., Jacobson L. P., Rodriguez B., Sterling T. R., Kirk G. D., Napravnik S., Rachlis A. R., Calzavara L. M., Horberg M. A., Silverberg M. J., Gebo K. A., Kushel M. B., Goedert J. J., McKaig R. G., Moore R. D., Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clinical Infectious Diseases 2009 49 10 1582 1590 2-s2.0-72849148114 10.1086/644768
8. Lohse N., Jorgensen L. B., Kronborg G., Moller A., Kvinesdal B., Sorensen H. T., Obel N., Gerstoft J., Gerstat J., Obel N., Kronborg G., Pedersen C., Larsen C. S., Pedersen G., Laursen A. L., Kvinesdal B., Moller A., Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure. Antiviral Therapy 2007 12 6 909 917 2-s2.0-34848922187 (Pubitemid 47492560)
9. Panidou E. T., Trikalinos T. A., Ioannidis J. P. A., Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis. AIDS 2004 18 16 2153 2161 2-s2.0-7744231500 10.1097/00002030- 200411050-00007 (Pubitemid 39463680)
10. Wegner S. A., Wallace M. R., Aronson N. E., Tasker S. A., Blazes D. L., Tamminga C., Fraser S., Dolan M. J., Stephan K. T., Michael N. L., Jagodzinski L. L., Vahey M. T., Gilcrest J. L., Tracy L., Milazzo M. J., Murphy D. J., McKenna P., Hertogs K., Rinehart A., Larder B., Birx D. L., Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial. Clinical Infectious Diseases 2004 38 5 723 730 2-s2.0-10744227842 10.1086/381266 (Pubitemid 38333870)
11. Cingolani A., Antinori A., Rizzo M. G., Murri R., Ammassari A., Baldini F., Di Giambenedetto S., Cauda R., De Luca A., Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (Argenta). AIDS 2002 16 3 369 379 2-s2.0-0037083803 10.1097/00002030-200202150-00008 (Pubitemid 34165368)
12. Palella F. J. Jr., Armon C., Buchacz K., Cole S. R., Chmiel J. S., Novak R. M., Wood K., Moorman A. C., Brooks J. T., The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Annals of Internal Medicine 2009 151 2 73 84 2-s2.0-67651089497
13. Hirsch M. S., Brun-Vézinet F., Clotet B., Conway B., Kuritzkes D. R., D'Aquila R. T., Demeter L. M., Hammer S. M., Johnson V. A., Loveday C., Mellors J. W., Jacobsen D. M., Richman D. D., Antiretroviral drug resistance testing in adults infected with human immunodefidency virus type 1: 2003 recommendations of an International AIDS Society-USA panel. Clinical Infectious Diseases 2003 37 1 113 128 2-s2.0-0038234808 10.1086/375597 (Pubitemid 36836653)
14. Hammer S. M., Eron J. J. Jr., Reiss P., Schooley R. T., Thompson M. A., Walmsley S., Cahn P., Fischl M. A., Gatell J. M., Hirsch M. S., Jacobsen D. M., Montaner J. S. G., Richman D. D., Yeni P. G., Volberding P. A., Antiretroviral treatment of adult HIV infection: 2008 Recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association 2008 300 5 555 570 2-s2.0-48949097660 10.1001/jama.300.5.555
15. Department of Health and Human Services Panel on Antiretroviral, Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. 2009 12 17
16. Buchacz K., Baker R. K., Young B., Brooks J. T., Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. Patients, 1999 to 2006. Journal of Acquired Immune Deficiency Syndromes 2010 53 5 625 632 2-s2.0-77950229001 10.1097/QAI.0b013e3181bf1dd2
17. Von Wyl V., Yerly S., Böni J., Bürgisser P., Klimkait T., Battegay M., Bernasconi E., Cavassini M., Furrer H., Hirschel B., Vernazza P. L., Francioli P., Bonhoeffer S., Ledergerber B., Günthard H. F., Long-term trends of HIV Type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical Infectious Diseases 2009 48 7 979 987 2-s2.0-63649085185 10.1086/597352
18. Lima V. D., Gill V. S., Yip B., Hogg R. S., Montaner J. S. G., Harrigan P. R., Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy. Journal of Infectious Diseases 2008 198 1 51 58 2-s2.0-46349091980 10.1086/588675 (Pubitemid 351920289)
19. Gill V. S., Lima V. D., Zhang W., Wynhoven B., Yip B., Hogg R. S., Montaner J. S. G., Harrigan P. R., Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clinical Infectious Diseases 2010 50 1 98 105 2-s2.0-72049086981 10.1086/648729
20. Audelin A. M., Lohse N., Obel N., Gerstoft J., Jorgensen L. B., The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005. Antiviral Therapy 2009 14 7 995 1000 2-s2.0-72249107557 10.3851/IMP1412
21. Gupta R. K., Hill A., Sawyer A. W., Cozzi-Lepri A., von Wyl V., Yerly S., Lima V. D., Günthard H. F., Gilks C., Pillay D., Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. The Lancet Infectious Diseases 2009 9 7 409 417 2-s2.0-67449097569 10.1016/S1473-3099(09)70136-7
22. Von Wyl V., Yerly S., Böni J., Bürgisser P., Klimkait T., Battegay M., Furrer H., Telenti A., Hirschel B., Vernazza P. L., Bernasconi E., Rickenbach M., Perrin L., Ledergerber B., Günthard H. F., Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of Internal Medicine 2007 167 16 1782 1790 2-s2.0-34548655652 10.1001/archinte.167. 16.1782 (Pubitemid 47403067)
23. Richman D. D., Morton S. C., Wrin T., Hellmann N., Berry S., Shapiro M. F., Bozzette S. A., The prevalence of antiretroviral drug resistance in the United States. AIDS 2004 18 10 1393 1401 2-s2.0-3142660152 10.1097/01.aids. 0000131310.52526.c7 (Pubitemid 38925131)
24. Gange S. J., Schneider M. F., Grant R. M., Liegler T., French A., Young M., Anastos K., Wilson T. E., Ponath C., Greenblatt R., Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. Journal of Acquired Immune Deficiency Syndromes 2006 41 1 68 74 2-s2.0-28944447391 10.1097/01.qai.0000174652.40782.4e (Pubitemid 41786022)
25. Napravnik S., Keys J. R., Quinlivan E. B., Wohl D. A., Mikeal O. V., Eron J. J., Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. AIDS 2007 21 7 825 834 2-s2.0-34147143531 10.1097/QAD.0b013e32805e8764 (Pubitemid 46573154)
26. Moorman A. C., Holmberg S. D., Marlowe S. I., Von Bargen J. C., Yangco B. G., Palella F. J., Ward D. J., Loveless M. O., Fuhrer J., Joseph P., Alexander W. A., Aschman D. J., Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS). Annals of Epidemiology 1999 9 6 349 357 2-s2.0-0033179077 10.1016/S1047-2797(99)00005-8 (Pubitemid 29378345)
27. Abraham A. G., aabraham@jhsph.edu Lau B., Deeks S., Moore R. D., Zhang J., Eron J., Harrigan R., Gill M. J., Kitahata M., Klein M., Napravnik S., Rachlis A., Rodriguez B., Rourke S., Benson C., Bosch R., Collier A., Gebo K., Goedert J., Hogg R., Horberg M., Jacobson L., Justice A., Kirk G., Martin J., Mckaig R., Silverberg M., Sterling T., Thorne J., Willig J., Gange S. J., Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in North America. American Journal of Epidemiology 2011 174 6 727 735 10.1093/aje/kwr141
28. Harrigan P. R., Hogg R. S., Dong W. W. Y., Yip B., Wynhoven B., Woodward J., Brumme C. J., Brumme Z. L., Mo T., Alexander C. S., Montaner J. S. G., Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. Journal of Infectious Diseases 2005 191 3 339 347 2-s2.0-19944431012 10.1086/427192 (Pubitemid 40139758)
29. Bansi L., Smith C., Phillips A., Kirk S., Geretti A. M., Johnson M., MacKie N., Post F., Gazzard B., Dunn D., Sabin C., The impact of HIV drug resistance testing on changes to treatment. AIDS 2011 25 5 603 610 2-s2.0-79952453762 10.1097/QAD.0b013e32834403a0